Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP” Jul 23, 2021
PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Jul 21, 2021
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan Jul 21, 2021
Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scientific Advisory Board Jul 20, 2021
Ayr Wellness Enters Illinois with Agreement to Acquire Herbal Remedies Dispensaries, LLC Jul 20, 2021
